Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,056.9
-7.7 (-0.25%)

 

  • STI Straits Times Index
    3,056.9
    -7.7 (-0.25%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,545.9
    -9.3 (-0.60%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    24,807.0
    139.2 (0.56%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,614.0
    6.9 (0.19%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    30,500.0
    176.7 (0.58%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,117.7
    7.8 (0.13%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,122.1M
  • Value: 984.9M
  • Rise: 143
  • Fall: 181
  • Unch: 430

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Hatten Land0.076+0.016
GSS Energy0.077+0.005
ESR-REIT0.470-0.015
Sembcorp Marine0.082-0.001
YZJ Shipbldg SGD1.470-0.040
Lippo Malls Tr0.054+0.003
Singtel2.420+0.020
Genting Sing0.735-0.005
VCPlus0.026+0.002
OUE Com Reit0.445-

World Indices

World Indices
Name Last Change
Nasdaq 15,181.9 +20.4
HSI 24,791.9 +124.1
HSCEI 8,883.3 +77.5
Jakarta 6,116.7 +6.8
Nikkei 225 30,500.0 +176.7
SSE Comp 3,614.0 +6.9
Shanghai A 3,787.7 +7.3
Shanghai B 273.1 -1.8
KOSPI 3,140.5 +10.4

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

PERKINELMER INC PERKINELMER INC
Updated on 16 Sep 2021 (End of trading day)
Last (USD): 185.870 Change: -0.970 High: 186.440 Remarks: -
Change (%): -0.52 Low: 182.900
Open 186.280 Yesterday's Close 186.84
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 770,461 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a 6.49426 Trailing EPS (USD) e 10.54680 NAV (USD) b 37.8169
PE a 28.621 Trailing PE f 17.623 Price / NAV b 4.9150
Dividend (USD) d 0.279940 Cash In Hand (USD) g 5.1248 Issued & Paid-up Shares c 112,114,000
Dividend Yield (%) d 0.151 Price / Cash In Hand g 36.269 Treasury Shares h -
Market Cap (M) 20,838.629 Enterprise Value (M) 22,806.595
Piotroski F Score 7 Exchange Code PKI Par Value ( $ ) n.a.
52 Weeks Volatility (%) 31.64 Free Float (%) 99.7
Sector & Industry Health Technology - Medical Specialties
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. The figure pertains to the respective exchange the stock is listed on. Updated on 11 Aug 2021.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 13 Jul 2015.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference PERKINELMER INC NYSE 20,838.629 28.621 17.623 4.9150 0.151
Industry Medical Specialties NYSE 44,605.048 48.972 35.460 4.9580 0.586
Local Peer DANAHER CORP NYSE 231,303.600 65.899 65.898 5.8576 0.221
Local Peer ABBOTT LABORATORIES NYSE 225,928.181 50.509 35.602 6.6843 1.199
Local Peer THERMO FISHER SCIENTIFIC INC NYSE 220,487.744 34.586 25.650 5.9827 0.158
Local Peer MEDTRONIC PLC NYSE 176,193.445 48.861 45.376 3.4222 1.848
Local Peer STRYKER CORP NYSE 104,119.977 65.116 49.986 7.5340 0.851
Local Peer EDWARDS LIFESCIENCES CORP NYSE 75,229.456 91.365 51.442 14.6552 -
Local Peer BECTON DICKINSON & CO NYSE 75,436.197 98.352 40.448 3.1259 1.230
Local Peer BOSTON SCIENTIFIC CORP NYSE 63,930.865 - 136.604 4.0102 -
Local Peer AGILENT TECHNOLOGIES INC NYSE 52,455.841 72.957 52.986 10.6057 0.420
Local Peer ALCON AG NYSE 43,159.089 - 235.842 2.2639 0.121
Local Peer KONINKLIJKE PHILIPS NV ADR EACH REP 1 ORD EUR0.20 NYSE 43,301.233 32.000 32.324 3.0550 2.159
Local Peer RESMED INC NYSE 41,690.989 87.862 87.862 14.4476 0.545
Other Local Peers BAXTER INTERNATIONAL INC (NYSE), METTLER-TOLEDO INTERNATIONAL INC (NYSE), WEST PHARMACEUTICAL SERVICES INC (NYSE), ZIMMER BIOMET HOLDINGS INC (NYSE), WATERS CORP (NYSE), BIO RAD LABORATORIES INC (NYSE), COOPER COS INC (NYSE), STERIS PLC (NYSE), TELEFLEX INC (NYSE), SMITH & NEPHEW ADR EACH REPR 2 ORD (NYSE), QIAGEN NV (NYSE), PENUMBRA INC (NYSE), HILL-ROM HOLDINGS INC (NYSE), GLOBUS MED INC (NYSE), ENVISTA HOLDINGS CORPORATION (NYSE), INSPIRE MEDICAL SYSTEMS INC (NYSE), NEVRO CORP (NYSE), CONMED CORP (NYSE), HAEMONETICS CORP (NYSE), GLAUKOS CORPORATION (NYSE), BUTTERFLY NETWORK INC (NYSE), AVANOS MEDICAL INC (NYSE), CRYOLIFE INC (NYSE), VAPOTHERM INC (NYSE), INVACARE CORP (NYSE)
Global Peer INTUITIVE SURGICAL INC NASDAQ 123,037.884 116.008 75.828 11.3530 -
Global Peer IDEXX LABORATORIES INC NASDAQ 56,443.606 97.019 77.549 75.5139 -
Global Peer ALIGN TECHNOLOGY INC NASDAQ 57,543.285 32.403 82.387 17.0025 -
Global Peer DEXCOM INC NASDAQ 54,675.706 110.769 103.045 27.3706 -
Global Peer GENMAB AS SPON ADS EACH REP 0.1 ORD SHS NASDAQ 27,769.969 38.166 68.843 8.5984 -
Global Peer INSULET CORPORATION NASDAQ 19,828.796 2,916.034 - 43.1906 -
Global Peer HOLOGIC INC NASDAQ 19,556.522 17.536 9.597 5.0441 -
Global Peer ABIOMED INC NASDAQ 16,240.212 72.011 105.175 12.4206 -
Global Peer MASIMO CORPORATION NASDAQ 15,083.388 62.768 67.429 10.8417 -
Global Peer DENTSPLY SIRONA INC NASDAQ 13,596.058 - 36.916 2.6796 0.643
Other Global Peers NOVOCURE LTD (NASDAQ), BRUKER CORPORATION (NASDAQ), FISHER & PAYKEL HEALTHCARE CORP (ASX), COCHLEAR LTD (ASX), MICROPORT (HKEx), TANDEM DIABETES CARE INC (NASDAQ), SHOCKWAVE MEDICAL INC (NASDAQ), WEIGAO GROUP (HKEx), SOTERA HEALTH CO (NASDAQ), ANGELALIGN (HKEx), STAAR SURGICAL CO (NASDAQ), Top Glove (SGX), TOPGLOV (Bursa), QUIDEL CORP (NASDAQ), INTEGRA LIFESCIENCES HLDGS CORP (NASDAQ), ICU MEDICAL INC (NASDAQ), HARTA (Bursa), INMODE LTD (NASDAQ), LIVANOVA PLC (NASDAQ), NEOGEN CORP (NASDAQ), ORTHO CLINICAL DIAGNOSTICS HLD PLC (NASDAQ), EBOS GROUP (ASX), MERIT MEDICAL SYSTEMS (NASDAQ), INARI MEDICAL INC (NASDAQ), CYTEK BIOSCIENCES INC (NASDAQ), CAREDX INC (NASDAQ), ATRICURE INC (NASDAQ), THE BEAUTY HEALTH COMPANY (NASDAQ), AXONICS INC (NASDAQ), NUVASIVE INC (NASDAQ), HESKA CORP (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), OUTSET MEDICAL INC (NASDAQ), VERICEL CORP (NASDAQ), VENUS MEDTECH-B (HKEx), CARDIOFLOW-B (HKEx), LIFETECH SCI (HKEx), SILK ROAD MEDICAL INC (NASDAQ), BIOLIFE SOLUTIONS INC (NASDAQ), PEIJIA-B (HKEx), IRHYTHM TECHNOLOGIES INC (NASDAQ), PROCEPT BIOROBOTICS CORP (NASDAQ), LANTHEUS HOLDINGS INC (NASDAQ), ESTABLISHMENT LABS HLDGS INC (NASDAQ), ZYLOXTB-B (HKEx), KANGJI MEDICAL (HKEx), SUPERMX (Bursa), INOVIO PHARMACEUTICALS INC (NASDAQ), MESA LABORATORIES INC (NASDAQ), TREACE MED CONCEPTS INC (NASDAQ), AK MEDICAL (HKEx), CARDIOVASCULAR SYSTEMS INC DEL (NASDAQ), PULMONX CORPORATION (NASDAQ), NANOSONICS LIMITED (ASX), ALPHATEC HLDGS INC (NASDAQ), ORTHOPEDIATRICS CORP (NASDAQ), SIGHT SCIENCES INC (NASDAQ), ATRION CORP (NASDAQ), LEMAITRE VASCULAR INC (NASDAQ), VAREX IMAGING CORPORATION (NASDAQ), INOGEN INC (NASDAQ), NANO-X IMAGING LTD (NASDAQ), CERUS CORP (NASDAQ), VIEWRAY INC (NASDAQ), ANGIODYNAMICS INC (NASDAQ), DERMTECH INC (NASDAQ), 908 DEVICES INC (NASDAQ), SINGULAR GENOMICS SYSTEMS INC (NASDAQ), CIRC (HKEx), CUTERA INC (NASDAQ), MODERN DENTAL (HKEx), TRANSMEDICS GROUP INC (NASDAQ), NATUS MEDICAL INC (NASDAQ), TACTILE SYSTEMS TECHNOLOGY INC (NASDAQ), EARGO INC (NASDAQ), BIOVENTUS INC (NASDAQ), ORTHOFIX MEDICAL INC (NASDAQ), SURMODICS INC (NASDAQ), INTERCURE LTD (NASDAQ), ORASURE TECHNOLOGIES INC (NASDAQ), SI BONE INC (NASDAQ), SISRAM MED (HKEx), CHUNLI MEDICAL (HKEx), NYXOAH SA (NASDAQ), AXOGEN INC (NASDAQ), KDL MEDICAL (HKEx), PAVMED INC (NASDAQ), ANTARES PHARMA INC (NASDAQ), INFUSYSTEM HOLDINGS INC (NYSE American), PULSE BIOSCIENCES INC (NASDAQ), ACOTEC-B (HKEx), SEASPINE HOLDINGS CORP (NASDAQ), HEARTCARE-B (HKEx), FLUIDIGM CORP DEL (NASDAQ), ITAMAR MEDICAL LTD SPON ADS EACH REP 30 ORD SHS (NASDAQ), AVITA MEDICAL INC (NASDAQ), SOLITON INC (NASDAQ), AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), METRICS INCOME OPPORTUNITIES TRUST (ASX), MISONIX INC (NASDAQ), IRADIMED CORP (NASDAQ), BASECARE-B (HKEx), NEUROPACE INC (NASDAQ), STEREOTAXIS INC (NYSE American), ZYNEX INC (NASDAQ), ATOSSA THERAPEUTICS INC (NASDAQ), TALIS BIOMEDICAL CORP (NASDAQ), CLEARPOINT NEURO INC (NASDAQ), APYX MEDICAL CORPORATION (NASDAQ), ACCELERATE DIAGNOSTICS INC (NASDAQ), RETRACTABLE TECHNOLOGIES INC (NYSE American), ACUTUS MEDICAL INC (NASDAQ), CYTOSORBENTS CORP (NASDAQ), SIENTRA INC (NASDAQ), ONCOCYTE CORP (NASDAQ), UTAH MEDICAL PRODUCTS (NASDAQ), YESTAR HEALTH (HKEx), CONFORMIS INC (NASDAQ), CVRX INC (NASDAQ), LUCIRA HEALTH INC (NASDAQ), INCANNEX HEALTHCARE LTD (ASX), ACCURAY INCORPORATED (NASDAQ), ICECURE MEDICAL LTD (NASDAQ), PROFOUND MED CORP (NASDAQ), QUOTIENT LTD (NASDAQ), APOLLO ENDOSURGERY INC (NASDAQ), AROA BIOSURGERY LTD (ASX), PW MEDTECH (HKEx), CLARITY PHARMACEUTICALS LTD (ASX), MYMD PHARMACEUTICALS INC (NASDAQ), VOLPARA HEALTH TECHNOLOGIES LTD (ASX), DARIOHEALTH CORP (NASDAQ), MEDICAL DEVELOPMENT INTL (ASX), ENLIVEX THERAPEUTICS LTD (NASDAQ), UGHealthcare (SGX), SURGALIGN HOLDINGS INC (NASDAQ), INTRICOM CORP (NASDAQ), Medtecs Intl (SGX), TELA BIO INC (NASDAQ), TITAN MEDICAL INC (NASDAQ), CORMEDIX INC (NASDAQ), COLLPLANT BIOTECHNOLOGIES LTD (NASDAQ), NEURONETICS INC (NASDAQ), NYMOX PHARMACEUTICALS CORP(BAHAMAS) (NASDAQ), EMVISION MEDICAL DEVICES LTD (ASX), NEMAURA MEDICAL INC (NASDAQ), SOMNOMED LIMITED (ASX), REPRO MEDSYSTEMS INC (NASDAQ), SECOND SIGHT MEDICAL PRODUCTS INC (NASDAQ), BRAINSWAY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), IMPEDIMED LIMITED (ASX), VENUS CONCEPT INC (NASDAQ), FONAR CORP (NASDAQ), ATOMO DIAGNOSTICS LIMITED (ASX), UNIVERSAL BIOSENSORS INC NPV (CDI) (ASX), LUMOS DIAGNOSTICS HOLDINGS LIMITED (ASX), IRIDEX CORP (NASDAQ), ALPHA PRO TECH (NYSE American), CYCLOPHARM LIMITED (ASX), OPTISCAN IMAGING (ASX), ELECTROMED INC (NYSE American), MEDAVAIL HOLDINGS INC (NASDAQ), KELFRED (HKEx), CRYO-CELL INTERNATIONAL INC (NASDAQ), BIOLASE INC (NASDAQ), BIOSIG TECHNOLOGIES INC (NASDAQ), MICRO-X LTD (ASX), CHECK-CAP LTD (NASDAQ), NEPHROS INC (NASDAQ), LENSAR INC (NASDAQ), SDI LTD (ASX), CELSION CORPORATION (NASDAQ), VINCENT MED (HKEx), VOLITIONRX LIMITED (NYSE American), HANCOCK JAFFE LABORATORIES INC (NASDAQ), ZOSANO PHARMA CORP (NASDAQ), AVINGER INC (NASDAQ), CLEANSPACE HOLDINGS LTD (ASX), CHEMBIO DIAGNOSTICS INC (NASDAQ), SOLENO THERAPEUTICS INC (NASDAQ), IMMUCELL CORP (NASDAQ), DELCATH SYSTEMS INC (NASDAQ), ELECTROCORE INC (NASDAQ), HELIUS MEDICAL TECHNOLOGIES INC (NASDAQ), PREDICTIVE ONCOLOGY INC (NASDAQ), MILESTONE SCIENTIFIC INC (NYSE American), RGTBHD (Bursa), NEUROMETRIX INC (NASDAQ), APPLIED UV INC (NASDAQ), STRATA SKIN SCIENCES INC (NASDAQ), REWALK ROBOTICS LTD (NASDAQ), SENSUS HEALTHCARE INC (NASDAQ), ROCKWELL MEDICAL INC (NASDAQ), NANOVIBRONIX INC (NASDAQ), YUNNAN ENERGY (HKEx), IMAGION BIOSYSTEMS LIMITED (ASX), DIMERIX LTD (ASX), EKSO BIONICS HOLDINGS INC (NASDAQ), AETHLON MEDICAL INC (NASDAQ), BIOMERICA INC (NASDAQ), COMPUMEDICS (ASX), ADVENTA (Bursa), NEOVASC INC (NASDAQ), TRINITY BIOTECH PLC ADR EACH REPR 4 CLS A ORD USD0.019 (NASDAQ), RESHAPE LIFESCIENCES INC (NASDAQ), DAXOR CORP (NYSE American), LKL (Bursa), CARDIEX LTD (ASX), RESPIRI LTD (ASX), NOVA EYE MEDICAL LIMITED (ASX), KEWAUNEE SCIENTIFIC CORP (NASDAQ), INSPIREMD INC (NASDAQ), BELLEROPHON THERAPEUTICS INC (NASDAQ), MOTUS GI HOLDINGS INC (NASDAQ), RESONANCE HEALTH LTD (ASX), TENAX THERAPEUTICS INC (NASDAQ), Yunnan Energy (SGX), MEDIGUS SPON ADS EACH REP 50 ORD SHS (POST SPLT) (NASDAQ), SINTX TECHNOLOGIES INC (NASDAQ), PETVIVO HLDGS INC (NASDAQ), ALLIED HEALTHCARE PRODUCTS INC (NASDAQ), LBT INNOVATIONS LTD (ASX), PLUS THERAPEUTICS INC (NASDAQ), THERMOGENESIS HOLDINGS INC (NASDAQ), Biolidics (SGX), ADHERIUM LIMITED (ASX), VIVEVE MEDICAL INC (NASDAQ), DYNATRONICS CORP (NASDAQ), INSPIRA TECH OXY BHN LTD (NASDAQ), NEUROTECH INTERNATIONAL LTD (ASX), XTANT MEDICAL HLDGS INC (NYSE American), RA MEDICAL SYSTEMS INC (NYSE American), OSPREY MEDICAL INC NPV DFD 23/09/21(EX-SPLIT) (ASX), ALLEGRA ORTHOPAEDICS LIMITED (ASX), CYANOTECH CORP (NASDAQ), OVENTUS MEDICAL LTD (ASX), NUWELLIS INC (NASDAQ), LIFE HEALTHCARE (HKEx), USCOM LTD (ASX), METALICITY LIMITED (ASX), TRUSCREEN GROUP LTD (ASX), STAR EQUITY HOLDINGS INC (NASDAQ), Annica (SGX), HUAKANG BIOMED (HKEx), ANALYTICA (ASX), STHAI (SET), OSPREY MEDICAL INC NPV (CHESS DEPOSITARY INTERESTS) (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --1.180
-0.63 %
10 Days --4.630
-2.43 %
20 Days -+4.770
+2.63 %
Medium Term Return 3 Months -+35.180
+23.35 %
6 Months -+57.470
+44.76 %
1 Year 9.590+67.670
+65.36 %
Long Term Return 2 Years 20.790+99.310
+138.75 %
3 Years 21.070+89.260
+114.20 %
5 Years 21.560+130.340
+273.55 %
Annualised Return Annualised --
+30.16 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 114.750 - 191.065 Change From 1 Year Low +71.120 % Change From 1 Year Low (%) +61.98
Change From 1 Year High -5.195 % Change From 1 Year High (%) -2.72
2 Years Range 62.910 - 191.065 Change From 2 Years Low +122.960 % Change From 2 Years Low (%) +195.45
Change From 2 Years High -5.195 % Change From 2 Years High (%) -2.72
5 Years Range 45.350 - 191.065 Change From 5 Years Low +140.520 % Change From 5 Years Low (%) +309.86
Change From 5 Years High -5.195 % Change From 5 Years High (%) -2.72
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

PerkinElmer, Inc. engages in the provision of products, services, and solutions for diagnostics, food, environmental, life sciences, and applied markets. It operates through the following segments: Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment comprises of technologies that help life sciences researchers better understand diseases and develop treatments. The Diagnostics segment offers instruments, reagents, assay platforms, and software to hospitals, medical labs, clinicians, and medical research professionals to help improve the health of families. The company was founded by Richard Scott Perkin and Charles W. Elmer on April 19, 1937 and is headquartered in Waltham, MA.

Historical Price Data

Date Open High Low Close Volume VWAP
16 Sep 2021 186.280 186.440 182.900 185.870 770,461 -
15 Sep 2021 183.320 188.350 182.040 186.840 1,119,355 -
14 Sep 2021 184.600 185.830 182.820 183.380 424,639 -
13 Sep 2021 188.030 188.030 178.610 182.860 755,749 -
10 Sep 2021 186.860 188.430 186.420 187.050 443,140 -
09 Sep 2021 190.500 190.890 186.420 186.850 477,249 -
08 Sep 2021 189.440 191.065 188.000 190.110 587,341 -
07 Sep 2021 189.740 190.920 187.270 189.820 653,743 -
03 Sep 2021 188.090 190.550 186.270 190.500 974,499 -
02 Sep 2021 189.100 190.590 188.400 188.830 619,173 -
01 Sep 2021 185.040 188.680 184.300 188.010 455,209 -
31 Aug 2021 188.440 188.500 183.760 184.800 600,762 -
30 Aug 2021 183.840 189.310 183.550 187.950 619,641 -
27 Aug 2021 184.190 186.840 182.590 182.910 438,360 -
26 Aug 2021 184.440 185.923 182.110 183.680 393,512 -
25 Aug 2021 181.780 185.390 181.260 185.020 488,054 -
24 Aug 2021 181.680 183.155 180.750 182.200 905,616 -
23 Aug 2021 182.640 183.620 181.280 181.510 498,771 -
20 Aug 2021 182.110 184.000 180.450 181.100 495,956 -
19 Aug 2021 180.060 182.790 179.280 181.770 623,660 -
18 Aug 2021 182.860 184.773 181.020 181.070 623,276 -
17 Aug 2021 184.060 184.790 180.720 182.850 703,106 -
Summary
Current 2 Weeks
(02 Sep 2021 to 16 Sep 2021)
189.100 191.065 178.610 185.870 6,825,349 -
Previous 2 Weeks
(19 Aug 2021 to 01 Sep 2021)
180.060 191.065 178.610 188.010 5,519,541 -
4 Weeks from
(22 Jul 2021 to 18 Aug 2021)
157.550 191.065 157.445 181.070 18,232,863 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.